Telomerase activity in B and T lymphocytes of patients with systemic lupus erythematosus

被引:23
作者
Klapper, W
Moosig, F
Sotnikova, A
Qian, W
Schröder, JO
Parwaresch, R
机构
[1] Univ Kiel, Dept Haematol, D-24105 Kiel, Germany
[2] Univ Kiel, Lymph Node Registry Kiel, D-24105 Kiel, Germany
[3] Univ Kiel, Dept Internal Med 2, D-24107 Kiel, Germany
[4] Zhejiang Univ, Affiliated Hosp 1, Dept Haematol, Hangzhou 310003, Peoples R China
关键词
D O I
10.1136/ard.2003.016022
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective: To evaluate telomerase activity as a marker of lymphocyte proliferation in systemic lupus erythematosus (SLE). Methods: CD19+, CD4+, and CD8+ lymphocytes were isolated from the peripheral blood of nine patients with SLE and nine healthy controls by means of magnetic bead-coupled antibodies and tested for telomerase activity with the TRAP assay. Results: Telomerase activity was significantly increased in CD19+ B cells from patients with SLE. CD4+ and CD8+ T cells from lupus patients displayed increased mean telomerase activity, although the difference from normal controls did not reach statistical significance. Conclusions: Increased telomerase activity in the B and the T cell lineage might indicate activation and proliferation of these lymphocytes.
引用
收藏
页码:1681 / 1683
页数:3
相关论文
共 50 条
  • [21] Lymphocytes Tγδ in clinically normal skin and peripheral blood of patients with systemic lupus erythematosus and their correlation with disease activity
    Robak, E
    Niewiadomska, H
    Robak, T
    Bartkowiak, J
    Blonski, JZ
    Wozniacka, A
    Pomorski, L
    Sysa-Jedrzejowska, A
    MEDIATORS OF INFLAMMATION, 2001, 10 (04) : 179 - 189
  • [22] CLONING OF T-LYMPHOCYTES IN SYSTEMIC LUPUS-ERYTHEMATOSUS
    WHITTINGHAM, S
    RODGER, B
    MATTHEWS, JV
    MACKAY, IR
    CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 1978, 34 (01) : 63 - 68
  • [23] THE ROLE OF LYMPHOCYTES-T IN SYSTEMIC LUPUS-ERYTHEMATOSUS
    ZUBLER, RH
    MIESCHER, PA
    ANNALES DE MEDECINE INTERNE, 1990, 141 (03): : 208 - 212
  • [24] B1 CD5+LYMPHOCYTES IN SYSTEMIC LUPUS ERYTHEMATOSUS PATIENTS: RELATION TO DISEASE ACTIVITY
    Nasef, S. I.
    Omar, H. H.
    Omar, H. H.
    Ghaly, M. S.
    ANNALS OF THE RHEUMATIC DISEASES, 2017, 76 : 1235 - 1235
  • [25] B-lymphocytes as Effectors and Regulators in systemic Lupus erythematosus
    Winkler, T. H.
    ZEITSCHRIFT FUR RHEUMATOLOGIE, 2014, 73 (04): : 360 - 362
  • [26] STIMULATION OF T-SUPPRESSOR LYMPHOCYTES WITH CONCANAVALIN A IN PATIENTS WITH SYSTEMIC LUPUS-ERYTHEMATOSUS
    CHU, LW
    LEWIS, JE
    LUNDAK, RL
    FEDERATION PROCEEDINGS, 1979, 38 (03) : 1463 - 1463
  • [27] Defective proliferative response of T lymphocytes from patients with inactive systemic lupus erythematosus
    Hernández-Fuentes, MP
    Reyes, E
    Prieto, A
    Zea, A
    Villa, L
    Sánchez-Atrio, A
    Esquivel, F
    Alvarez-Mon, M
    JOURNAL OF RHEUMATOLOGY, 1999, 26 (07) : 1518 - 1526
  • [28] Interferon therapy effects on activation of T-lymphocytes in patients with systemic lupus erythematosus
    Stanislav, ML
    Balabanova, RM
    Nikonova, MF
    Litvina, MM
    Yarilin, AA
    TERAPEVTICHESKII ARKHIV, 2000, 72 (05) : 44 - 49
  • [29] B-lymphocytes as Effectors and Regulators in systemic Lupus erythematosus
    Winkler, T. H.
    ZEITSCHRIFT FUR RHEUMATOLOGIE, 2014, 73 (04): : 360 - 362
  • [30] Increase in activated CD8+T lymphocytes expressing perforin and granzyme B correlates with disease activity in patients with systemic lupus erythematosus
    Blanco, P
    Pitard, V
    Viallard, JF
    Taupin, JL
    Pellegrin, JL
    Moreau, JF
    ARTHRITIS AND RHEUMATISM, 2005, 52 (01): : 201 - 211